Dose Modification News Today

Explore dosing nuances and adverse event management strategies for afatinib in treating EGFR mutant non-small cell lung cancer, reflecting real-world practices and clinical insights.

Rachel Layman, MD, summarizes how to dose CDK4/6 inhibitors in different clinical settings.

A panel of oncologists shares comprehensive insight to clinical trial data with tucatinib in patients with HER2+ metastatic colorectal cancer.

Singapore: Recent study by Jia Qi Yeo and team found, metabolite monitoring of thiopurine therapy against inflammatory bowel disease (IBD) enables rapid dose optimization or therapy escalation for...